Trials / Terminated
TerminatedNCT04432779
Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children
Impact of SARS-CoV-2 Infection During Pregnancy on Newborns and Young Children
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,362 (actual)
- Sponsor
- Centre Hospitalier Universitaire Saint Pierre · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study aim is to assess impact of COVID-19 infection during pregnancy on outcome of pregnancy, and on developement of the child in early life.
Detailed description
All pregnant women will be tested for serology during each trimester of pregnancy and at delivery, together with a nasal swab. Children born to women with positive sawb or serology will be followed up for 3 years together with a control child born to negative mother. In positive mothers, maternal antibodies at delivery will be characterized, placental transfer will be assessed. Persistence of antibodies in children at the age of 1 month and presence of antibodies in breast milk will be measured. Occurence of premature birth, low birth weight, miscarriage, congenital malformations will be compared in positive and negative mothers. Follow up of children over the first 3 years of life will assess difference in susceptibility to infections and neurological developement in both groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention | no intervention |
Timeline
- Start date
- 2020-05-25
- Primary completion
- 2020-10-06
- Completion
- 2022-03-01
- First posted
- 2020-06-16
- Last updated
- 2024-08-26
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04432779. Inclusion in this directory is not an endorsement.